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Few syndromes in medicine have as bizarre and 
often as catastrophic features as Granulocytopenia. 
Confined to no sex or age group, it hi t.s rich ·and 
poor alike. Known for only a short time, it assumes 
increasing importance as medicine enters its chemo-
therapeutic age. Even now, forty years after the first 
recorded observations on the disease, there is con-
siderable confusion regarding it. Some investigators 
feel that they deal with a group of diseases rather 
than a single disease entity. This paper, arranged in 
more or less text book fashion, represents a review 
of the established observations with particular em-
phasis on the later literature and the relation of the 
syndrome to the drugs of the para-amino-benzene-sul-
fonamide series. 
DEFINITION 
Granulocytopenia is a disturbance of the hema-
topoietic system caused by various known and unknown 
factors. It is a syndrome rather than a disease and 
is characterized by an acute febrile course with high 
mortality, ulcerative lesions of the mucus membranes, 
particularly in the oral cavity, and a striking leuk-
openia, in which there is a complete or almost complete 
absence of cells of the gr8.nulocytic variety. 'l'he bone 
marrow may be normal, hypoplastic or hyperplastic. 
HISTORY 
Blood counts have been made 1n large hospitals 
for the past fifty years. Never the less, the disease 
was reported with such extreme rarity prior to 1922 
that we usually date it from the observations of Sc~1ltz 
in tnat year. 
Pepper (65), in his history of malignant heutro-
penia, stated that th~ disease was mentioned in laryngo-
logic works of sixty years ago as "putrid sore throat", 
and "gangrenous angina", and he said that Mackenzie, 
ln his manual of diseases of the nose and throat, cred-
ited Gubler, in 1857 and Trousseau, in I865 with having 
distinguished the disease from diptheria. The first case 
reported in this ccuntry was that of Brown (9) in I902. 
This was reported as acute primary, infectious pharyn-
gitis with extreme leukopenia and terminated fatally. 
Turck (88) reported one case in I907. Leale (53) in I9IO, 
reported a case in a male child two and one half years 
old under the title "Recurrent Furunculosis in an In-
fant Showing an Unusual Blood Picture." 
Baldridge and Needles (62), In I9IO, reported a 
case and pointed out that in former years it was either 
overlooked because the blood was not examined or was 
interpreted as a symptom of bone marrow Ohaustion, 
apla.stic anemia, or a.leukemic leukemia. 
Schultz(84) in I922 described fully four cases 
in middle aged women characterized by severe leukopenia, 
a decrease or absence of granular cells in the blood, 
gangrenous throat lesions and a rapid, septic course 
with death in from two to seven days. He noted the 
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normal red count, the frequent jaundice, the paucity 
of myeloid cells found in the bone marrow at autopsy. 
Since this description many similar cases have been 
reported, particularly from Germany and Ameri.ca. Many 
of the cases have departed in one or more particulars from 
this "Schultz" type. Uur concept of the? condition has 
changed gradually as it has become apparent that a large 
number of bacterial, toxic, chemical and physical agents 
can produce a very similar picture. The group of cases 
designated "idiopathic" is becoming steadily smaller 
as definite etiological agents are discovered. 
NOMENCLATURE 
Since the description of Werner Schultz in I922, 
many attempts to standardize the nomenclature have been 
made. Schultz proposed the term 11Agranulocytosis". This 
term, while brief, is ambiguous. By ''agranulocytes n are 
meant those neutrophiles without granulations which are 
seen in blood smears from cases of leukemia. The term 
"Agranulocytosis" suggests an increase in these atypical 
neutrophiles, quite the opposite from the impression 
desired. 
The name '1Agranulocytic Angina", perhaps in greater 
use th"oi.ll any other, was proposed by Friedemann (28) who 
was impressed by the usual localization of lesions in 
the throat. This term has the same intrinsic ambiguity 
regarding the granulocytf:s as the first one mentioned 
and is doubly undesirable in the light of later day 
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knowledge that cases do exist without a.ngina. 
Schilling (82), suggested the term "malignant 
Neutropenia" which contains no ambiguities but does 
not recognize that there are also benign and recurrent 
forms. 
Rosenthall (76) in his classification divided 
neutropenia into malignant (fatal) and benign (recov-
r:ired) cases. 
Many other terms have been suggested, such as 
agranulosis, mucositis necroticans agranulocytica, 
monocytic angina, sepsis with granulopenia, idiopathic 
neutropenia and pernicious leukopenia. 
Beck (4) has suggested a rather adequate class-
ification into I. primary benign and primary malig-
nant neutropenia in which the etiology is unknown; 
2. secondary benign and secondary malignant neutropenia, 
the cases in which the etiologic agents are evident 
or in which one is dealing with well recognized clinical 
entities. 
For a simple term covering the syndrome in a 
general way I should like to propose the name "Gran-
ulocytopenia". This is a trifle more descriptive than 
the term ttNeutropenia" and conveys the idea that there 
is a shortage of cells of the granulocytic series. 
ETIOLOGY 
During the short time that we have recognized the 
syndrome of granulocytopenia our conception of it has 
changed tremenduosly. Werner Schultz advanced no theory 
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as to the cause of it. He remarked that it seemed to 
occur in women and was invariably fatal. (Since that 
time numerous cases have occured in males and numerous 
cases have recovered.) 
Hueper (33) found a. ratio of three and one half 
women to one man, or 77.5 'ftc in women. Roberts and Kracke 
(7'6) presented a table compiled from 8,000 leukocyte 
and differential counts which showed this trend in 
chronic cases (56 ~being in females). The majority of 
cases seem to occur in the fourth decade of life. 
Cases have occured i.n children, in young adults and 
in very old people, but these are more rare. The two 
countries which seem to have the greatest incidence 
are Germany and the United States. 
Gordon (29) in his article on the etiology and 
treatment of granulocytopenia has given a classification 
factors 
of the various which have at one time or another been 
incriminated in the production of the syndrome. 
A. Unknown- the malignant neutropenia of Schultz. 
·B. Chemicals and drugs - benzol, hydrocarbon, tri-
nitre-toluene, arsenobenzol, bismuth, bismarsen, amide-
pyrine, barbital, dinitrophenone etc. 
c. Bacteria - streptococci of all types, staphylo-
cocci ( aureus and albus), Vincents' spirillum and the 
fusiform bacillus, pneumococcus, gram negative and 
gram pbsitive cocci, gram negative and gram positive 
bacilli, bacillus coli, bacillus pyocyaneus, bacillus 
subtilis, bacillus dipth'::!riae, the meningococcus and 
the gas gangrene bacillus. 
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D. Malignant neutropenia has developed in people 
under treatment for; cholecystitis, cardiac disease, 
arthritis, amebic and ulcerative colitis, furuncu1osis, 
syphilis, tuberculosis and cancer. 
E • .Allergy, particularly asthma, has been reported 
to be one of the causes of malignant neutropenia. 
F. A congenital condition of the bone marrow has 
been demonstrated and a maturation arrest described 
by some authorities as a cause. 
G. ?iologically, it has followed the use of proph-
ylactic typhoid serum and diptheria anti-toxin. 
H. Physically it has followed the use of x-ray 
therapy. Extraction of teeth and fractures of bone 
have been described as etiological factors. 
I. The menses and pregnancy have been described 
as etiological factors •. 
(Gordon does not feed that drugs are the predom-
inant etiological factor. In his series of 59 cases 
only one had taken medicines of the benzene series. This 
view is concurred in by T.H. Boughten of Akron, Ohio, 
who states that in the rubber factories where benzene 
is in general use among the workers he has seen a great 
many cases of benzene poisoning, yet in spite of con-
stant watchfulness has seen only two cases of agranulo-
cytosis, neither of the workers having been exposed to 
any form of industrial poisoning.) (54) 
On the opposite side of the fence may be b alanced 
the clHssic work of Kracke and his associates, (41-46) 
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(63) who in 1934 declared flatfootedly that "acute 
fulminant granulopenia and other types as well are 
caused for the most part by th~ administration of 
easily oxidizable benzene ring drugs? I" Others of 
their conc1usions were: not the benzene nucleus it-
self, but an axidizable end product of it (quinone 
or catechol) is at fault. This was proven by inject-
ing rabbits with benzene, inducing granulopenia and 
recovering catechol from the bone marrow. They also 
oxidized amidopyrine and phenacetine, two of the drugs 
more commonly associated with granulocytopenia, and 
proved by chemical reactions and spectrum analysis 
that one ofthe end products was quinone. 
In an analysis of 1314 cases, four drugs were 
incriminated by Kracke and associates: gold salts, 
arsphenamine, amidopyrine and phenacetin. It was 
pointed out that these all have certain structures 
in common, the benzene grouping with an attached 
amino radical. Straight chain barbiturates they did 
not incriminate but those with the benzene nucleus 
were found to be associated with the syndrome. 
Kracke and associates also pointed out the 
quite interesting and significant fact that physicians, 
nurses, pharmacists and those in eontact with benzene 
drugs have a far greater incidence as a class. 
In an address delivered before the 1940 meeting 
of the Omaha Midwest Clinical Society, Dr. Kracke 
listed several other drugs which have been found at 
times to be associated with the syndrome.These include 
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dinitrophenol, used to reduce weight, gold salts, used 
in arthritis, organic arsenical compounds, used in 
syphilis therapy, and the sulfanila.mide derivatives. 
The flaw, of course, in the theory of the causation 
of the syndrome by drugs alone is that their action 
can not be predicted and it is impossible to effect a 
reduction of the human white count by experiment«.:.l 
giving of the drugs. Apparently some peculiar set of 
circumstances must be present in the body economy 'ere 
the neutropenic state can be induced by the coal tar 
products and others. Parker and Kra.<"!ke (63) have re-
cently suggested 'that the reduced form of glutathione 
plays an important part in the regulation of bone marrow 
activity. They find this substance to be markedly re-
duced in the bone marrow and blood of animals in which 
granulocytopenia has been produced by benzene. 
Farley (20) reviewed from the literature thirty 
nine cases in which the function of the bone marrow 
was depressed_following the use of various preparations 
of arsphenamine. The symptoms varied from those of pur-
"'' 
pura hemorrhagica to those of severe aplastic anemia and 
malignant neutropenia, depending on whether the prine!-
iple effect was on the granulopoietic, megakaryopoietic 
or erythroblastic tissues, or on all of these combined. 
Madison and Squier were the first to incriminate 
amidopyrine, especially in combination with a barbiturate, 
as a cause of granulocytopenia. They found that the 
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onset of granulopenia was often directly preceded by 
the use of amidopyrine alone. Several oftheir patients 
were known to have a normal blood count and even a 
leukocytosis before the use of the drug. 
Imerman and Imerman (34) in 1936 reported 8 cases 
of granulocytopenia developing from the use of dinitro-
phenol to r8duce w~ight. All eight patients ~ere women 
and their ages ranged from I8 to 48 years. The drug was 
used within apparently normal limits in every case. 
The most important pro-dromal symptoms occurred from 
ten days to four months after the drug was started and 
consisted of fever, sore throat and headache. Five of. 
the patients recovered (the five who received perit-
nucleotide therapy). The other patients, treated with 
adenine sulfate, liver extract and blood transfusions 
died. 
Many other drugs have been mentioned, a fe~,v of 
which are antipyrine, acetanilid, atophan, phenacetin, 
novaldin, nirvanol, quinine, plasmochin and neostibosan. 
Amidopyrine, however, remains the chief of'fender and 
no more Bloquent testimony can be given than the amaz-
ing decrease in the incidence of the di:3ease not only 
in Denmark but also in the United States since the .dan-
ger ofthe drug has b een popularized. That amidopyrine 
is not the whole story is shown by incidents in whi~h 
patients known to be suf f8ring from granulocytopenia 
were given amidopyrine as- a sedative with complete 
recovery following. (71) 
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In approximately one third of the cases of gran-
ulocytop0nia, the blood culture is positive for some 
organism. This usually represents secondary infection, 
hmvever, resulting from the depressed white count. 
'T'he concept has been held by numerous authors th<,.t 
granulocytopenia is an infectious disease. (I5, 2I, 90, 
93). Attempts to induce the disea:-3e by introducing into 
animals organisms isolated from lesions, hone marrow 
and blood stream of patients have failed to give any 
conclusive informe.tfon. A large number of patients 
give a history of Vincent's angina prior to the clini~al 
onset. This may well be the result of an unrecognized 
granulocytopenia of a chronic nature. 
Fried and Dameshek (27) induced neutropenia ex-
perimentally by innoculating the blood stream of rabbits 
with the organism Salmonella Buipestifer. By grading the 
size of the dose they were able to produce two types 
of cases, those in whi~h the animal recovered and ful-
minating cases ending fatally. The blood picture showed 
leukopenia and neutropenia but not a clear cut granulo-
cytopenic picture. 
Piersol and Steinfield (66) found that a long 
continued granulopenia conld not be induced in healthy 
rabbits by the use of a small group of common bacteria. 
A distinction should probably be made between 
marked secondary leukopenia and neutropenia due to an 
infection, and primary neutropenia in which the primary 
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lesion is in the blood or bone marrow and the organisms 
growing in a system devoid of granulocytes. If this 
distinction be kep:t in mind it would seem that it is 
attacking the etiology from the wrong standpoint to 
attempt to exhaust the bone marrow by the introduction 
of organisms. 
In Dennis' experiments (I6), various organisms 
derived from neutropenic patients were placed in parch-
ment capsules and within the peritoneal cavity of an-
imals to produce the condition. The animals having the 
most suggestive results showed on post-mortem examin-
ation , pneumcmcti, whi::!h were not among the bacteria 
tested. 
Some very interesting work, the results of which 
have not yet been published, has been done by Lawrence 
(52) and his associates. They have produced in cats a 
disease similar to the hum.an disorder and labelled 
"Infectious Feline Agranulocytosis". This has been shown 
to be due to a filterable virus and shows pronounced 
granulocytopenia on the sixth to ninth day after ex-
posure. Inthe bone marrow there is invariably absence 
of differentiation into late myeloid forms at the 
height of the disease. The mechanism in both the human 
a.nd the feline forms they feel may be due to peripheral 
destruction. The very sudden disappearance of neutrophiles 
following amidopyrine would suggest this. In the eat 
a transfusion with one third a body volume of blood 
from another cat with the same quantity removed from 
the stricken animal by cardiac p1mcture was unable to 
elevate tile white count and the granulocyte count- also 
suggesting peripheral destruction. 
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This theory that a fil t·;rable virus m<;_y be the cau3e 
of the granulocytop,~nic syndrome is extremely inter-
esting and entirely plausible but would seem to await 
much more confirmation. Zikciwski (94) in I93I ::;hared thL: 
view suggesting that a virus having a special affinity 
for granulopoietic tissue might induce a severe form 
of sepsis in the weakened organism, injuring not only 
the granulopoietic system but paralyzing the organ com-
plex (liver, spleen and e"docrine glands) which stim-
ulate the bone marrow and govern the release of white 
cells into the blood stream. 
A few authors believe that granulocytopenia may 
be a form of allergy in which the bone marrow is the 
area afflicted. Schilling (82), a name to be conjured 
with in blood picture interpretation, has this view-
point. He was able to experimentally produce a blood 
picture similar to granulocytopenia by inducing ana-
phylaxis. Bromberg and Murphy (6I) reported a case 
following prophylactic typhoid vaccination. Kraoke 
reported a case and said; "The question of typhoid 
prophylaxis as a whole or partial cause of the con-
dition must be considered." Meyer reported a case 
following malarial therapy. Those cases showing eosin-
ophilia during an attack suggest i:i.naphylaxis. 
A rather interesting parallel is drawn by R.C. 
Beck (4) between granulocytopenia and pernicious 
anemia. Granulocytopenia in its recurrent phase is 
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somewhat similar in its clinical cour3e to per-
nicious anemia. 
Cr:;.stle called attention to the intrinsic and 
extrinsic factors which are missing in pernicious 
anemia, and Beck postulates a chf~motactic and mat-
uration factor which may be mis '>ing in granulocyto-
penia. The marked therapeutic action of pentnucleo-
tide extract may be due to these factors contained 
in it. 
This concept is supported by the fact that there 
can be marked myeloid hyperplasia accompanying the 
neutropenia - in fact there can be any type of my-
eloid tissue. Beck's theory presupposes a chemotactic 
substance present in the broken down products of white 
cells (nucleic acid and its degradation products) which 
stimulates the bone marrow to myeloid activity. Thus 
stimulated, a maturation factor al~rn present in the 
bone marrow comes into play. In a normal or hyper-
pl&stic bone marrow this second, maturation factor 
is assumed to be missing. 
There is good evidence that diet may play a prom-
inent part in the production of the; syndrome. Miller 
and Rhoads (59) developed an ulcerative stomatitis in 
dogs by means of a diet causing blacktongue (Goldber-
ger' s diet). The terminal features of the illness vVere; 
I. Ulcerative, gangrenous stomatitis with spiral and 
fusiform organism~ 
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2. Leukopenia, granulopenia and a suppressio11. of the 
hematopo1etic elements of the bone marrow. 
Lillie demonstrated lesions of the myelin sheaths 
of the nerves lea.ding to the ulcerated areas - hence 
assuming the mucus membr&nr~ change to be trophic in 
nature. Total absence of granulocytes was nE:~ver ohs-
erved ! 
The bone marro·N changes 'Nere: I. A di la ta tiun of 
capillaries. 2. A cessation of maturation of hemato-
poietic cells. These are the identical changes pro-
duced by the administratlon of certain toxic, aromatic 
compounds of the benzene series. 
The re la ti on between IDfms trua ti on and th•2 agranulo-
cytic syndrome has been often noted. W.P. Thompsen (87) 
found that in 17 out of 18 young women vl/i th granulocy:t-
openia, symptoms began within a day or two of menstruation. 
All were menstruating upoh hospital admission. One or 
more recurrences were observed in six of these - each 
with the onset of ca.tamenia. Two young women with prev-
ious attacks of granulocytopenia were followed through 
a menstrual period. In both a distinct but transient 
neutropenia developed with symptoms just before cata-
menia. The excretion of female sex and gonadotropic: 
hormones was followed through the neutropenic phase of 
a well known male case of cyclic granulocytopenia. The 
results suggest that neutropenia occurs, in this young 
man, at the time of hormonal catamenia. (This patient 
developed within two years a diabetes insipidus - also 
interesting is the fact that they Nere able to abort 
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a scheduled attack with pentnucleotide extract. In this 
patient the fall in granulocytes definitely precedes 
the fever, buccal necrosis and other symptoms.) 
A familial tendency to granulocutop:mia is a 
possibility. Hart (32) suggested this having observed 
the syndrome in two sisters. Wolf (SI) reported gran-
ulocytopenia as reactions to the 3ame infection in 
brother and sister. Congenital granulopoietic insuff-
iciency seems to exist in some cases but the granulo-
poietic tissue in most of the familial linked cases 
seems to have functioned normally for many years. 
Blumer dismissed the possibility of a congenital 
anomaly with this statem;nt; "The same patient has 
reacted with the usual leukocytosis and granulocyt-
osis to one attack of an infection and has shown a 
leukopenic and neutropenic reaction to another attackl" 
The possibility of a constitutionally limited bone 
marrow would seem as yet a theoretical 1uestion. 
PATHOLOGY 
The absence of white cells of the granulocytic 
series accounts for the high incidence of blood 
cultures, the anginal lesions and the peculiar form 
of inflammation which accompanies both benign and malig-
nant granulocytopenia. Tissue ulceration and necrosis 
lack the exudative features of the normal reaction 
ac companied by polymorphonuclear leukocytic infilt-
ration. Lymphocytes may be present, also macrophage 
cells and endothelial cells. Infection spreads like 
wildfire due to the lack of development of an inflam-
matory barrier. Any site in the body where bacteria 
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normally flourish may become the site of focal infection. 
This is particfilarly true of the g~stro-intestinal tract. 
Ordinary inhabitants of this system me.y gain the ascen-
dency to become pathogenic. 
'Pone marrow infection may oc::!ur. Muller in his series 
of cases of influenza found that the red marrow had been 
invaded by organisms and damag(~d e.nough to interfere 
with granulopoiesis. The yellow marro·N was not damaged 
and there was evidence to show that it had taken over 
some of the function of th''' red marr·ov1r. The hone marrow 
has never been shown to be infected in granulocytopenia 
save in the terminal stages of a septicemia but it would 
seem logical that this could occur - particularly in a 
fulminating case with an absence of granulocytes. 
In f a.tal cases of granulocytopenia the bone marrow 
is degenerated to a very great extent. It varies in color 
from red to straw and may be liquified. Areas of patchy 
necrosis may be seen. The myelocytes and polymorpho-
nuclear cells are absent or nearly so. Normoblasts and 
megakaryocytes are present in their normal numhers. 
With the maintenance of the gross, fatty structure, 
granulocytes may be ab3ent or nearly so but erythro-
cy.tes, lymphocytes and endothelial leuko~ytes may be 
present. Generally the bone marrow is in a state of 
myeloid hypoplasia or aplasia. It may be normal as 
to myeloid elements and cases have beo:m reported with 
a myeloid hyperplasia. 
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The condition of the spleen largelJ hinges on 
the septic or toxic proces:~es that occur. Enlargement 
of the spleen, seen in some cases, is due to a tremend-
uous increase in the reticulo-endothelial cells which 
outnumber the lymphoid cells. The splenic '>inu';es are 
filled with erythrocytes, reticulo-endothelial cells 
and lymphoid cells. Small anemic infarcts are occasion-
ally seen. 
The lymph follicles are small and atrophic~ and 
there are no lymphoblasts or young.cells in the germ-
inal centers, only mature lymphocytes. The cervical, 
sub-maxillary, peribronchial and mesenteric groups 
are frequently enlarged and may contain hemorrhages. 
The liver is often enlarged and may show cloudy 
swelling. There is an increase in Kupffer's cells, 
bile pigment in the hepatic cells.and bile casts in 
the capillaries. Sometimes there are interstitial 
lymphocytic infiltrations and there may be small, 
multiple foci of necrosis. 
The lungs are· frequently the site of a pneumonic: 
process. The gross picture is similar to influenzal 
pneumonia. There is diffuse edema of a hemorrhagic 
type with no sign of inflammation and little phag-
ocytosis. Sub pleural hemorrhages are frequently ob-
sBrved. 
LABORATORY 
Blood examlnation is, of course, extremely nec-
cessary both in the diagnosis of the condition and in 
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fol.lowing the results of therapy. Blood counts should 
be made at the same hour every day for comparable re-
sults and preferabll_\ twice or three timr:;s per day. 
This takes cognizance of the leukoC)'te tides whi:!h 
occur daily. 
The most outstanding laboratory finding is the 
leukopenia. In a severe case' the total white cells may 
be so low as to be uncountable. In practir::ally e.11 cases 
the white count is below 2,000 and in some cases has 
been reported as low as 200. It may be necessary to 
use a I:IO dilution of the blood rather than the usual 
1:20. 
The second most striking finding from a laboratory 
standpoint is the neutropenia. The morphology of the 
· neutrophilic granulocytes is normal. There are no a-
typical cells, but their number is depleted to around 
30 or 40 % in the chronic and less severe cases and 
there may be a complete absence in the fulminating 
cases. 
Krumbhaar (48) recognized a terminal rise in the 
number of immature granulocytes in fatal cases o~ mus-
tard gas poisoning. He labelled it "myelocytic crisis". 
Schilling (82) called this a "degenerative shift" and 
explained it on a disbalance between maturation and 
chemotactic factors. The supply of maturation factor 
having been depleted, the normally functioning chemo-
tactic factor delivers immature myelocytes to the 
peripheral blood. This does not mean necessarily that 
the patient is recovering. It may be just an "agonal 
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outpouring" of thr~ last of the young cells. 
Eosinophiles may be either absent, present irt 
normal quantities or in excess of the normal quant-
ity. The same is true of basophiles. 
The lymphocytes are, in most cases, greatly re-
duced. Their morphology rema.ins perfectly normal. 
The mechanism of their reduction is obscure as there is 
no evidence of destruction of lymphoid tissue. 
Monocytes and transitional cells become reduced 
in number as the disease becomes more sevr:;re. Their 
morphology remains normal. Ferrata (22) theorized that 
the macrophage cells of the reticulo-endothelial sys-
tem might acquire granules and take over the work of 
the granulocytes in the emergency. He found such cells 
in the blood stream, containing eith~r basophilic o~ 
eosinophilic granulations and termed them "hemohist-
iocytes". 
If the disease lasts more than the usus.l ten days 
there may be a diminution of erythrocytes. In fulmin-
ating cases the erythrocytes are not affected because 
there is not time. When anemia is present it is usually 
of the:~ secondary type with hypochromia. 
In malignant granulocytopenia due to benzene or 
other drugs the blood platelets are reduced. In other 
forms of the disease they remain normal unless the bone 
marrow becomes aplc:..stic. 
-20-
Rutledge and hL; assoclates (78) found that 
during an attack the motility and viability of the 
granulocytes was much reduced, and their capacity to 
take the neutral red dye diminished. ~he motility 
never approached normal and their average length of 
life was only one-half normal. 
Roberts and Kracke performed. the following ex-
periments to determine the toxicity of the serum. 
Vllhen their patient'$ white count totalled 400, they 
took 2 c·.c. of the patient's blood (ox&.lated) and 
mixed it with 2 c.c. of normal blood of the same type. 
A normal control was set up •. Differential an~ total 
white counts were made at two hour interv<:1.ls for 48 
hours but neutrophilic destruction could not be dem-
onstrated. Other experiments have had similar results 
and one may say that sufficient proof is not at hand 
regarding the toxicity of serum in granulocytopenia. 
Biopsy on the sternal ms.rrow is the best mr:~thod 
for differentiation between granulocytopenia with 
a maturation arrest and granulocytop8nia with myeloid 
aplasia; and in aiding the differential diagnosis 
versus other bone marrow dise<:ses. Biopsy on the fresh 
specimen of bone marrow is far superior to the spec-
imen observed at autopsy. 
The urine in granulocytopenia is not significant 
and the findings are those of any other febrile disease. 
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Many ca~'>es have a negative blood culture. 1r,:nen 
positive the organisms most frequently found are the 
streptococcus viridans and hemolyticus, the staphylo-
coc·::us aureus, pneumococcus, colon bacillus and the 
bacillus pyocyaneus. 
Cultures from the mouth and throat reveal the 
normal inhabitants of th!is area, Vincent'~' s pirillurn, 
the fusiform bacillus, pneumococci, s treptoco'.::ci and 
staphylococci. Their abundance is in direct ratio to 
the decline of granulocytes. 
SYMPTOMS AND CLINICAL COURSE 
There are two clinical types of the syndrome 
recognized, the acute, and the chronic o~ recurrent. 
In the former the onset is abrupt with a chill, high 
fever, and oftentimes a necrotizing angina. There may 
be extreme prostration, hd<.idache, vomiting, muscle 
pains and delerium suggesting sepsis .. Jaundice and 
albuminuria are present in a certain pereentage of 
cases. The blood shows an extreme degree of 1eukopenia 
and neutropenia. The ulceration and necrosis re:>embles 
diptheria and may t.nvol ve tonsils, pharynx, gums, tongue, 
larynx, esophagus and more rarely the skin, rectum, 
vulva, vagina or perineum. These ulcers are non-marg-
inated with overhanging edges and a complete absence 
of surrounding inflammatory zone. The lymph nodes of 
the neck are usually enlarged and the liver and spleen 
may or may not be palpable. Petechiae have been desc-
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ribed Jn a few instances. The urine may show casts 
and bile. Signs of bronchopneumonia are pror1e to dev-
elop in the terminal stages of the dise~se. 
The chronic, recurrent form of:' the dis0ase may 
be rel&tively mild with symptoms of exhaµstion or of 
a low grade infection. Patients with this typi:; may 
have sevf..:r::;.l attacks with weeks or mon+,hs e1a.psing 
in between. This condition, with slight remissions, 
may persist for ye<::t.rs or the p&tif'.mt m::.y succumb 
during an acute exacerbation. 
The presence of an ulcerative or exudative. 
lesion in the throat or mouth should always suggest 
the necessity for a blood examination as well as a 
culture. The neutropenia precedes all symptoms accord-
ing to the bulk of the liter~ture on the subj~ct. · 
To wait for the appearance of sore throat, fever and 
angina is merely giving the army of orgRnisms a chance 
to invade the tissues. 
A·:typical history is the appearance of sore throat 
in a middle aged, usually debilitated individual, acc-
ompanied by chills and fever, ulceration and then mem-
brane formation in the throat and on the buccal mur~ous 
membrane. If angina is absent, and few cli-nical signs 
are present, the diagnosis is far more difficult. 
A total leukocyte and differential count should 
precede the r~xtraction of teeth and tonsillectomy. 
If angina and fever are both absent and there are only 
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weakness, malc..ise c:~nd dro1vs iness, a frequent leukoc::yte 
and diff8rential count should be made. Some authors state 
that normal numrers of circulating erythrocytes and thromb-
ocytes are essen~ial to the diagnosis and do not ac2ept as 
granulocytopenia any case in which there is an ahsolute 
decrease in lymphocytes or endothelial· leukocytes. 
A sternal marrow biopsy wou!d aid in the diagnosis 
and in distinguishing the aplastic from the hyperplastic 
type. Plum (68) hc.s studied the bone mc-.rrow by pun~ture 
at various stages of the disease and states that the 
prodromal marrow shows a depression of immature gran-
ulocytes with normal mature cPlls. The fully developed 
condition is marked by absence of granulocytes and 
increase of myeloblusts. The beginning of regeneration 
is manifested by incipieµt production of granulocytes, 
increase in myeloblasts and 'pre-myelocytes but no adult 
granulocytes. 
DIFFERENTIAL 
Acute, follicular tonsillitis, Vincent's angina 
and dipth~ria are to be differentiated by routine leuk-
ocyte and differential counts and appropriate clinical 
means. None of the afore-mentioned causes a leukopenia. 
Patients with streptococcic sore throat with 
streptococcus hemolyticus septicemia usually have leuk-
openia but sP-ldom less than 4,000 cells and the differ-
ential count usually shows at least 85 % neutrophiles. 
In typhoid C<ises and in influenza the leukocyte count is 
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rarely less than 4,000 and the neutrophilic percent-
age is at least 25. Generalized, rapidly advancing 
tuberculosis may show a marked, progressive leuko-
penia, as low a.s 3,000 cells, but the neutrophiles 
comprise from 90 to fi9 %, mostly immature forrr::s. 
Pneumonia may at times cause leukopenia, rarely 
below 6,000 cells and there is always a preponderance 
of neutrophiles. 
The condition known as lympho-sarcoma mfay cause 
leukopenia with a reduction in neutrophiles. Biopsy 
findings from the enlarged lymph glands vdll make this 
differentiation clear. 
Aleukemic leukemia is characterized by an anemia 
and usually a thrombocytopenia. The anemia is marked, 
progressive and of a macrocytic type. In granulocyto-
penia, anemia is rare and of a rnicrocytic type. In leuk-
emia, blast forms appear eventually although they may 
not be present at the onset. Nucleated red cells are 
found and considerable bleeding from the gums occurs. 
The disease lasts a longer time than granulocytopenia. 
In acute leukemia there is a very high cell count 
and there are large numbers of immature cells with the 
stem cells predominant. Acute leukemia is common in 
childhood and patients with a temperature of !02-4 deg-
rees seem comparatively well. In granulocytopenia there 
is a very low cell count and very few stem cells and 
other young forms are present. Over 20 % of stem cells 
usually means leukemia. The syndrome of granulocytopenia 
is rare in childhood and temperatures of 102-4 degrees 
usually mec;n prostration. In lymphatic reaction!"'· 
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there is an absolute increase in lymphocytes 'Which 
replace the neutrophiles to make the total leukocyte 
count normal or increased. Th<~re are usually many 
abnormal lymphoid cells, while in granulocytopenia the 
lymphoid cells are normal. Even so, the differential 
diagnosis is so difficult as to be well nigh impossible. 
The bone marrow biopsy will establish the diagnosis 
in doubtful cases. In the leukemias there is a c:::rowding 
of the marrow with lymphoid cells. 
Aplasia of the bone marrow (aplastic anemia) has 
anemia, thrombocytopenia and usually hemorrhagic pneu-
monia present. The disease is protracted and the bone 
marrow will often show a depletion of all jts elements. 
There are sub-cutaneous hemorrhages from mueus membranes 
and other parts of the body. There is aplasia of the 
bone marrow as a whole. The yellow marrow is devoid of 
erythrocytes, leukocytes and megakaryocytes. There are 
leukopenia, neutropenia, thrombocytopenia and rapidly 
advam::ing hyperchromic anemia. Thr:;re is a. re la ti ve inc-
rease in lymphocytes and the; color index is irrP15ular. 
If anemia is present it is of the secondary type and the 
erythrocytes are more or less achromic. 
Infectious mononucleosis usually occurs in young 
adults, often in their early twenties. Lymphadenopathy 
is often generalized, the spleen is palpable in many 
cases, leukocytosis is common, and the lymphocytes may 
show fenestration or vacuolization of their nuclei. 
The absolute.number of neutrophiles is usually not re-
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duced and many of them are immature. The injection of 
foreign protein will result in an increase in the nurr:her 
of circulating neutrophiles. The clinical manifestations 
are usually much less severe than in granulocytopenia. 
Care must be taken also to differentiate pernicious 
anemia in an aplastic phase and metastasis to the bones 
from neoplastic processes. 
TREATMENT 
All schools of thought agree that the primary 
step in therapy is to find the causs of injury to the 
bone marrow, if such cause can be isolated, and to re-
move it. History of the use of amidopyrine, dini troph(mol, 
gold salts, arsenicals, and numr:rous proprietary remed-
ies should be especially sought for. 
A review of the literature would suggest that most 
authors believe that a specific agent in therapy has 
not been found. The fact that some cases show spontan-
eous remission would make this rather hard to check. 
N(~ver-the-less, there are numerous measures advocated. 
and each has its enthusiastic supporters. 
Friedemann (28), in 1927, advocated "stimulating" 
doses of x-rays. He applied one-tvrentieth of an erythema 
dose of roentgen rays to the bones of the skeleton giv-
ing from one to two treatments at intervals of from two 
to several days. He reported that improvement from this 
th·::rapy may begin within from 24 to 48 hours, both as to 
clinical and blood picture. In the adult, the marrow in 
the long bones is mainly adipose tissue having little or 
no blood forming function. When pathologic demand exists 
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there is a formation of new centers by differentiation 
. of the myeloblasts into gr<mular myelocytes, the adipose 
tissue of the bone marrow being replaced by this newly 
formed tissue .• One theory is that it aids in the formation 
of this new tissue. There is no evidence, however, that 
a cell is affected in any but a destructive way by the 
roentgen ray. 
Dean's theory is that x-rays benefit those cases 
having a hyperplcistic myeloid tissue. The rays bring 
about a destruction of this tissue with a liberation of 
autogenous nucleotide, which then initiates the mat-
uration and delivery of granulocytes from the remo.ining 
myeloid foci. 
It is definitely known, however, that the x-ray 
will bring about a reduction in the actual numbers of 
white c_ells of both granulocytic and l;/mphocytic patterns 
and the consensus of opinion seems to be that it might 
be a distinctly dangerous proceedure by causing further 
bone.marrow depletion. 
_The nucleic acid derivatives offer the most hope 
along the line of specific theraps-utic measures. Rez-
nikoff (7I) introduced the use of intravenous adenine 
sulfate on the assumption that nucleic acid derivatives 
stimulate polymorphonuclear production. This is given 
in one gram doses, dissolved in ~O c.c. of saline brought 
to a boil. It is given as warm as the patient can stand 
as it goes out of solution 8asily. Thrombosis may occur 
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if some enters th~ wall of a vein and if it enters 
the surrounding tissues, nc3cros1s and even sloughing. 
may occur. Three doses for three days is usually ad-
equate if the drug is effective. 
In 193~~, Jackson, Parker and Taylor (2:i4) introduced 
pentnucleotide. They advocated the injection of IO c.c. 
intra-musculb.r ly four times a day if possible. ~~rr.a.11 
doses of I c .c. are increased hourly until th<:: above 
quantity is being given. An unpleasant reaction mani-
fests itself by a sense .of c·::nstriction in the chest, 
pounding in the head and general distress. 
Jackson (36) was the first to demonstrate that 
pentose nucleotide existed in normal human blood. It 
is known to exist principally in the nuclei of living 
cells. Doan and his co-workers showed that granulocytes 
could be called from the marrow by the split products 
of nucleic acid, adenine and guanine, and there was no 
transitory leukopenia due to splenic storage. These 
substances, given intravenously to rabbits, caused a 
marked increase in the number of circulating gran-
ulocytes without affecting the other cells. 
Doan, experimenting on normal rabbits with pen-
tose nucleotide, produced not only an extensive degree 
of myeloid hyperplasia, but also an extra medullary 
myelopoiesis in the kidneys and spleen. 
The nucleoproteins of the body exist as combin-
ations of nucleic acid with protein material. The acid 
is found within the ce:ill in free form in cases. The 
amount and character of the protein with which the free 
acid combines is variable. Those tissues which contain 
the largest amount of nuclear material are richest in 
nucleic acid. This includes such tissues as thymus, 
spleen, liver and hematopoietic tissue. Nucleic acids 
on hydrolysis yield the purine and pyrimidine nucleotides. 
The purine nucleotides on hydrolysis yield the purine 
bases, adenine and guanine. 
Jackson and associates (35) in their series of 
cases used the unbroken pentose nucleotide K-96 under 
the direction of Harvard Medical School. Twenty patients 
were treated. Of the thirteen whose condition could be 
classed as malignant, seven recovered. The first sign of 
improvement occured on the fifth day usually. The con-
sistency of this they compared with the Teticuloctte 
raise which occurs in pernicious anemia following liver 
therapy. Jackson and his workers concluded: "We believe 
that these nucleotides may have a definitely favorable 
effect on the very active bone marrow and in certain 
cases we believe the substance well worth trial." 
Gordon (29) has classified the types of treatment 
which have been employed in granulocytopenia; 
A. Blood - intravenous, intramuscular and intra-
peritoneally - both·h~~althy and that from a recovered 
case. 
P. Biological - nucleinic acid, nucleotide, leuk-
ocytic cream, bone marrow, sterile milk and foreign 
proteins. 
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c. Bacteriological - typhoid vaccine, ~acterio­
phage and bacterial serums. 
D. Glandular - mainly from the liver, fetal spleen, 
thyroid and adrPnals. 
E. Physical - x-rays, radium and sterile abscesses. 
F. Chemical - adenine sulfate, purine base, calcium 
sulfate, arsphenamine. 
G. General - allied stimulation, intravenous glucose, 
intravenous saline, diet and locally mouth washes, irr-
igations, oral hygiene. 
Gordon's successful treatment is as follows: 
I. A high nuclein diet. 
2. General therapy as mentioned above. 
3. Small blood transfusions - (contra-indicated 
where there are signs of liver exhaustion such as jaundice 
as an increased strain on the liver will cause blood to 
be broken down.) 
4. 40 c.c. of whole blood intramuscularly twice a 
day. 
5. Nucleotide and nucleinic acid. 
We have seen that diet may play a very important role 
in the etiology of theis condition. If this be true, it 
should follow that it might also prove important in ther-
apy. Doan was able to reduce the red marrow of the rad-
ius of pidgeons to an extreme hypoplasia by underfeeding. 
The work of Miller and Hhoades (59) in the prod-
uction of acute stomatitis with neutropenia and granulo-
cytopenia in dogs by means of a black tongue diet would 
strongly suggest that a diet rich in vitamin B should be 
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of material aid. 
In granulocytopenia due to arsphenamine very good 
results have been h.::.i.d. from the intravenous u;;e of sod-
ium thiosulfate. This can also be given by mouth. i'vlc -
bride and Dennie suggested that it be given in not more 
than 20 c.c. of distilled water, with daily intravenous 
injections for four days, and then on alternate days, 
for as many injections as may be neccessary, in doses 
starting with • 3 gram and increasing by • I5 gram da'ily. 
This drug is non-toxic in quantities up to 2 grams. 
The prodromal signs of toxicity are itching and a mild 
rash, prolonged fever and a tendency toward purpura .. 
Spleenectomy has been advocated in this condition 
and has been tried. It is generally conceeded, however, 
that the proceedure is poorly suited to the form of 
pathology present in these cases. 
Tr<:tnsfu':lions have been used in many of the cases 
reported, some recovering and some dying. Heports, on 
the whole,, have been satisfactory al though the proc(~edure 
is essentially emperical. There is no evidence that 
transfusions stimulate the neutrophilic development, 
and the number of neutrophi.les added in 5CO c. c. of 
blood would be of little assistance, particularly as 
the life of a neutrophile is short (5 days). Th0re is 
a possibility that blood from a healthy donor mi~ht 
have the principles to bring about normal maturation 
but here again it is highly conjectural and the amount 
woulq be small. 
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Reznikoff (7I) feels that fatigue is a definite 
factor in the production of th,,, syndrome. He reasons 
that treatment should include absolute re':;t and fr8e-
dom from worry as far as pos~ible. The chronic cases 
in particular improve with rest. 
Reznikoff has a theory regarding the action of 
liver, quite actively used in therapy. He states that 
the myeloid elements of the bon; marrow are in close 
contiguity with the hyperplastic, erythroblastic tissue 
and may be influenced by changes in the latter. With 
response to liver therapy the leukocytes usually inc-
rease (in.pernicious anemia anyway) and with this in 
view mcny workers have been giving intravenous liver 
extrac~ for acute granulocytopenia. Many favorable 
reports have been given. 
Miscellaneous agents which have been given inc-
lude turpentine to produce a local abscess, intra-
muscular injections of milk, intravenous injections 
of gentian violet and acriflavine; all have been used 
to stimulate the production of granulocytes, but to 
no avail. Leukocytic cream, typhoid vaccine, bacterio-
phage and bacterial serums have all been used. Gland-
ular extracts include those from thyroid, adrenals, 
spleen, liver. Other recommended measures have been 
elsewhere mentioned. 
General measures include treatment of th8 oral 
lesions. Sodium perborate gargles followed by swabbing 
of the ulcers with a two percent solution of copper 
sulfate should be used five times per day. 
Foci of infection should be cleare8 up with 
P'' rticuhjr referencE: to the oral cavity. :clJrgery 
should be undertaken if absolutely neccessnry. 
Abscesses should he localized and drained just as 
with a norme;l blood connt. 
A diet rich in vitamin "P" complex s~ems ~o 
have value, especihlly jn the chronic cases. 
Fluids should be forced. ~ome autho~ities 
rrc~commencl giving as high as five or six luarts per 
day. 
It might be well to m8ntion herR one recent 
and 1.,•:atkins of the 1h:iyo clinic with good results. 
This is extract of yellow bone marrow. The dosage 
r;i}1 ·: ' 
, ,t L.1 o..' 
type of therapy is said to produ~e a response in 
~A to 1-8 hours, whereas pentn11r~l00'.~.ide therapy tc-J.kes 
from four to five days. This bone marrow is given 
orally and does not produc:e the ;evere, painful 
reactions of pentnuclGotide. 
While no one therapr,iutic mea:::;ure me:;.y be hailed 
as specific, th'; enthusiastic end or ;i:;mc;:,nt ::;i vc;n a few 
of the ahove n-i;mtioned me <n.rres would ~-::ert;ain.ly c:eerr: 
to m0Ti t their further s t-,udy. 
TH? n~1ATIONsn1p o~ GRhNDLOCYT1PB~IA 
TO THS SUL~o~~VIDE r~RIV~TIVPS 
Since the middle of the l~st d0cade, a new era 
in ~Eedici11e ht~.s arise.11.. T1a1~·eJ_J 2d. the (~;.ge of cherno-
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therapy, enthusiasm has centered around one group 
of drugs; those of the sulfonamide series. Variously 
known as the "magic drugs", and the "wonder drngs", 
their use has become universal and their efficacy 
proven for all time. Unfortunately, .they are·not 
V'li thout their dangers, dangers bound to be magnified 
through the promiscuous use - and misuse which always 
follows in the wake of such a discovery. One of the 
graver complications of the use of these drugs is 
the development of granulocytopenia. The complication 
is particularly sinister in that the toxic effects may 
occur days after cessation of the drug, and relatively 
few clinical manifestat:i.ons occur until the syndrome 
is definitely established. Reznikoff (7I) predicts 
that ~he sulfonamide derivatives will replace amidopyrine 
as the number one cause of granulocytopenia. 
To illustrate the type of granulocytopenic syn-
drome which follo•.·\'s on the heels of sulfonamide ther-
apy, its method tf induction, time of onset, outcome, 
and some therap~t1tic measures which ha·ve been used to combat 
it; I have deemed it wise to select at random some 
case histories from the current literature. Many of 
these have points in common, but in gen·~ral thf:.>re are 
enough variable features that one hesitates to predict 
the action of the drug in any given .3et of circumstances. 
This unpredictability remaJ.ns the g:rea t mystery of 
granulocytopenia. 'Nhy the sulfonamide drugs should aid 
the white cells in one person and depl8te them in another 
is beyond the scope of our present knowledge. 
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Schwartz, Garwin and Koletsky (83) report a 
case of fatal granulocytopenia following sulfanila-
mide therapy. The case, a chronic, penile ulcer. 
The treatment consisted of 5 grams of sulf-
anilamide for two days, then two grams daily for 
three days. A routine blood colint at this time 
showed total leukocytes to be in the neighborhood 
of 2,000. The drug was stopped at the end of 2I 
days when the patient had received a total of 56.6 
grams. Four days later the patient was icteric with 
the liver well below the costal margin. There was 
slight necrotic ulceration in the tonsillar region. 
Dea th occurred on the following day. The nec:!ropsy 
included a myeloid series of th•; bone marrow which 
showed maturation arrest with s'tem 'cell hyperplasia 
and complete absence of more mature cells. 
Berg and Holtzmann (5) report the case of a 
man, age 22, in excellent health, who rec~ived sulf-
anilamide th.,:rapy for gonorrhea. 
Five grains ware given every four hours for five 
days at which time the patient developed slight fever, 
cramps and nauJea. The sulfanilamide was stopped al-
together, to be started four days later. After ingestion 
of a total of 38 grams he had a chill, fever, uncontroll-
able vomiting and abdominal pain. The diastolic blood 
pressure was 50, pulse 130, temperature I07 degrees. A 
blood count revealed a total absence of polymorphonuclear 
cells. Death occurred in spite of pentnucleotide therapy. 
-36-
F.D. Johnston (40) r?ported a case in a woman, 
age 23, who was treated for a pw:rperal infection due 
to the hemolytic streptococcus, group A. 6I.3 grams of 
prontosil was given both orally and intravenously over 
a 20 day period. A blood count at this time showed a 
total white count of I500 with no granulocytes and a 
severe secondary anemia. Thi"!rapy for the granulocytopenia 
consisted of a drip transfusion of defibrinated blood 
given over a 28 hour period. Pentnucleotide injections 
were given twice daily for 5 days (.35 g.). The pat-
ient was well two weeks later with a. white count of 
7550 - normal differential • 
. Johnson also reported a case which followed the 
treatment of acute pemphigus with M. and B. 693. 
The patient, a male age 29, was admitted to the 
hospital in profound toxemia with a temperature of 
I03 degrees, pulse of II6, respirations 20. There were 
inch wide lesions covering the entire body. These 
lesions were bullae filled with clear fluid. The res-
ponse to M. and B. 693 was dramatic after only ~-58 
grams of the drug had been given, but the patient had 
a white count of 6000, with only I? rf polymorphs., of 
which 90 % were immature. Pentnucleotide thE~rapy was 
started and the blood pict11re rapidly became normal. 
Sakula reports (BI) the treatment of a case of 
meningitis due to the Pfeiffer bacillus with M. and ~. 
693, which was complicated by granulocytopenia. 
The patient, age 2-l years, was admitted to the 
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hospital with a temperature of 103 degrees, pulse 128, 
respirations 48. Neurological signs were positive for 
meningitis. Culture of the spinal fluid proved Hemo-
philus Influenzae. 2.5 grams of M and B 693 were given 
per day. When I7 grams had been given the drug was 
stopped, due to a generalized rubella rash all ovP-r 
trunk and limbs. The white count was 23, 000 ·~ri th 79 % 
neutrophiles. By the next day the rash was gone. Five 
days later the temperature and pulse, wh.ich had been 
normal, ro;::;.e again and the drug was again given in 
doses of 2 grams per day for 5 days. At the end of the 
five days the leukocyte count had .fall.en to 2,IOO with 
5 % neutrophil~~s. Pentnucleotide was given for 9 days 
at the encl of which time the white count was I5,500 
with 58 % granulocytes. 
J.G.G. Borst has reported (8) a case of death 
resulting from an a.granulocytic complication of treat-
ment with prontosil flavum. 
The patient, age SI, was admitted to the hospital 
with a temperature of I02 degrees, white count of 8,000 
with 5I ~ polymorphs. The diagnosis was pyelocystitis. 
For ten days she received 6 tablets per day of prontostl 
flavum (300 mg. per tablet). Her symptoms disappeared, 
the tempc::rature dropped and the urine bec<:J.me pus and 
bacillus free. prontosil was stopped and the pyelo-
cystitis returned. Prontosil was resumed at the same 
dosage for ~~O more days . .A routine white count at this t'tne. 
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showed a total of 1225 with 2i % polymorphs. Two 
days later the patient's throat was red, swallowing 
was difficult and death ensued. The white count at the 
time of death was 960 with I % polymorphs., 87 oJ lymph-
ocytes and I2 % monocytes. (Prontosil flavurn is usually 
given to patients suffering from acute streptococcal 
sepsis and where the illness is already severe, slight 
symptoms of intoxication are not recognized easily so 
that not even a serious complication like granulocytopenia 
will alter the picture radically enough to attract 
attention. The importance of routine blood counts is 
again emphasized.) 
Jennings and Southwell-Sander report (39) a case 
developing in a housewife, age 39, with a diagnosis of 
ulcerative colitis with stool culture positive for 
dysentery bacilli. 
Sulfanilamide, four grams per day, was given for 
three weeks. The infection disappeared and the patient 
was discharged as well. Five days after quitting the dr0g, 
there was a temperature of I03.5 degrees. The pharynx 
wa::> reddened with a white exudate. The total 'Nhi te 
count was 444 with a complete absence of granulocytes. 
The treatment consisted of pentnucleotide, .7 gram intra-
muscularly twice a day for 3 days then once per day for 
2 days. The temperature became normal in 2 days. The 
white count returned to normal in one week. 
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Long, Haviland, Edwards and Bliss (56) have 
given an excellent analysis of the toxic manifestat-
ions of sulfanilamide and its derivatives. They have 
analyzed the incidence and types of toxic reactions 
occuring in ho~Jpitalized results, l,000 of whom were 
treated with sulfanilamide, 297 with sulfapyridine 
and 29I with sulfathiazole in Johns Hopkin's hospital 
over a period of years. 
They conclude that leukopenia with granulopenia 
may occur early or late in the course of therapy with 
sulfanilamide or its derivatives. They have noted a 
sharp drop in total leukocytes in certain cases follow-
ing a single dose, in other cases not showing up until 
60 or 70 days after treatment. No deaths have been 
reported from disturbances of the white cells during the 
first I2 days of therapy. 
They state further that acute granulocytopenia is 
a rare occurence and the most common time of appearance 
is from the I7th to the 25th day. Hence the blood count 
should be checked daily from the 12th day on. Stop the 
drug and vigorously force fluids in any decrease of 
total white ce1ls and polymorphs _. The forcing . of fluids 
helps to rid the body oft.he drug. Transfusions are t8 
be used when the hemoglobin value fall's below 70 %. 
The prognosis is good when the toxic reaction is recog-
nized in its inception. 
At the time of visit to one of these patients, the 
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physician should inquire as to his symptoms -
especially in respect to headache, body aching and 
malaise. These are often the precursors of ms.ny of 
the toxic reactions to sulfanilamide or its deriv-
atives. The sclera should be examined for jaundice, 
the mucus membranes for pallor and the skin for ev-
idences of rash. The temperature should always be taken 
in order to det,;ct whether drug fever is present. 
Lastly, one should remember that if a patient 
has once had a toxic reaction with one of these drugs, 
the next time the therapy is instituted he is likely to 
have an earlier and more severe reaction. Patients hav-
ing a toxic reaction to one of these drugs may have a 
similar reaction when another of the group is prescribed. 
The following table shows the incidence of granulo-
cytopenia which they found in this series. 
SULFANILAMIDE SULFAPYRIDINE 
in .I % of cases; in .3 % of cases; 
occurs on I4th to I4th to 40th day, 
40th day, more fre- I7th to ~5th mostly. 




but may occur. 
The prognosis in grmulocytopenia is always grave, 
the mortality being at least 75 ~. The outlook appears 
to be more serious with severe grades of leukopenia and 
complete absence of polymorphonuclear cells from the 
blood, though even these cases may recover. Total mono-
cytes numbering IOO to 200 are believed to be of favor-
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able import. The appearance of eosinophiles, a pro-
gressive rise in the white count and in the number of 
granulocytes are good omens. In general th~ outlook 
will depend upon the kind and degree of bone marrow 
injury, the degree of secondary infection a~d the gen-
eral recuperative power of the marrow. 
SUMMARY 
l. Granulocytopenia is a syndrome characterized 
by an acute, febrile course, neutropenia, ulcerative 
lesions of the mucus membranes, and a high mortality. 
2. Although probably existing prior to 1922, we 
usually date it from Schultz' observations in that year. 
Our concept of the disease has changed gradually as 
it has become apparent that a large number of bacterial, 
toxic, chemical and physical agents can produce it. 
The group of cases designated "idiopathic" is becoming 
steadily smaller as more of these agents are discovered. 
3. The term "agranulocytic angina", in greater 
use than any other, is somewhat ambiguous, as are many 
other of the suggested names. The term "granulocytopenia" 
is brief, descriptive, and contains no ambiguities. 
4. Perhaps the most outstandlng work in estab-
lishing the etiology of the condition was that of Kracke, 
who incriminated drugs containing the benzene nucleus. 
Many other drugs, not containing this radical, have been 
shown to produce the syndrome; as well as bacteria, phys-
ical agents, sera and antitoxins. A congenital condition· 
of the bone marrow has been demonstrated in some cases. 
Allergy has been found closely associated in some cases. 
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A clos1::; relationship to the menses and pregnancy has 
long been noted. Dietary factors and the possibility of 
a virus cause have recently been m~ntioned in the lit-
erature. 
5. The most striking pathological finding is the 
total or relative absence of white .cells of the gran-
ulocytic series in both bone marrow and the peripheral 
circulation. The bone marrow at autopsy may be normal, 
hypoplasic or hyperplastic. Most of the other pathology 
is secondary, contingent upon the reduced leukocytic 
defenses of the body. 
- 6. Diagnosis of the condition is fairly easy pro-
vided frequent blood examinations are made. Leukopenia 
and extreme neutropenia are the outstanding findings. 
Differential diagnosis versus aleukemic leukemia and 
other rare blood diseases is difficult but possible 
by a strict analysis of the blood picture and the 
clinical findings. The presence of an ulcerative lesion 
in the mouth or throat should always suggest the necessity 
for a blood examination. 
The primary step in therapy.is to find the cause 
of injury to the bone marrow and remove it .• No specific 
has been discovered for the c ondi ti on al th01.-!gh mRny 
have been suggested and tried. The most promisin~ of 
these are the nucleic.acid derivatives, adenine sul-
fate and bone marrow extract. Supportive measures 
include frequent transfusions, removal of foci of in-
fection and treatment of the local lesions. Due to the 
tendency toward spontaneous recovery, the results of 
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any therapy are difficult to evaluate. 
8. Granulocytopenia can be definitely caused by 
drugs of the sulphonamide series. Several case his-
tories and the results of a series of I,588 cases upon 
which records were kept at Johns Hopkins hospital are 
presented to illustrate this; The extremely common 
useage of these drugs make this complication an im-
portant consideration, particularly as the granulocyt-
openia may be latent, arising days after the drug -has 
been discontinued. Blood examination should be done 
frequently during the course of therapy with these 
drugs. Failure to do this is almost criminal negligence. 
9. The prognosis is extremely grave in granulo-
cytopenia r"~sul ting from any cau:~e V\Thatsoever. Drugs 
known to cause the condition should be avoided where-
ever possible. Drugs in common use by the laity should 
be labelled as to contents, and the public should be 
instructed to avoid pain relieving or soporific drugs 
about which they have no knowledge. These precautions, 
accompanied by frequent and thorough blood examinations 
upon the part of the physician, should do much toward 
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